DOCETAXEL vs TAXOTERE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 9, 2026·How we rate

Attribute	DOCETAXEL	TAXOTERE
Rating	72/100	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	DOCETAXEL	DOCETAXEL
Manufacturer	Ingenus Pharms LLC	Sanofi Aventis US
Dosage forms	Injectable, Solution	Injectable
Drug class	Microtubule Inhibitor	Microtubule Inhibitor
Boxed warning	None	Boxed warning
Treats	Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Head and Neck Neoplasms	Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Head and Neck Neoplasms

docetaxel taxotere

Rating

72/100

70/100

Pharmacy pays

—

Type

Active ingredient

DOCETAXEL

Manufacturer

Ingenus Pharms LLC

Sanofi Aventis US

Dosage forms

Injectable, Solution

Injectable

Drug class

Microtubule Inhibitor

Boxed warning

None

Boxed warning

Treats

Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Head and Neck Neoplasms

Frequently asked questions

Which is better-rated, Docetaxel or Taxotere?

By our independent rating, Docetaxel scores higher — 3.6 vs 3.5 out of 5 for Taxotere. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Docetaxel and Taxotere?

Both Docetaxel and Taxotere share the active ingredient Docetaxel.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.